The Future of the Diabetes Care Devices Market to 2016 -The Key Demand Drivers Remain Intact

Report Summary

GBI Research’s new report, “The Future of the Diabetes Care Devices Market to 2016-The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories -glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

• Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Global Market size and company share data for three diabetes care devices market categories - glucose monitoring and insulin delivery.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
• Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
• Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
• Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy

• Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the diabetes care devices market landscape? - Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8

2 Diabetes: Disease Overview 9
2.1 Type 1 Diabetes 9
2.2 Type 2 Diabetes 9
2.3 Impaired Glucose Tolerance 10
2.4 Diabetes Accentuating Cardiovascular Disease 10
2.4.1 Atherosclerosis 10
2.4.2 Diabetic Cardiomyopathy (DCM) 10
2.4.3 Stroke 11
2.4.4 Renal Disease 11
2.5 Diabetes a Burden on Healthcare Spending 11

3 Diabetes Care Devices Market: Market Characterization 12
3.1 Global Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 12
3.2 Global Diabetes Care Devices Market, Revenue Forecasts ($m), 2009 - 2016 13
3.3 Diabetes Care Devices, Key Market Trends 13
3.3.1 Home Healthcare Driving Growth in the Diabetes Care Devices Market 13
3.3.2 Brand Loyalty in Diabetes Care Devices Depends on Innovation and Price 14
3.3.3 Low Reimbursement for New Diabetes Care Technologies Restraining the Market 14
3.3.4 Drug Stores to Remain the Major Distribution Channels for Diabetes Care Devices 15
3.4 Diabetes Care Devices: Technological Trends 16
3.4.1 Innovation in Diabetes Care Devices Aimed at Enhancing Life of Diabetics 16
3.4.2 Continuous Glucose Monitoring (CGM) to Position Itself as a Major Diabetes Monitoring Technology 16
3.4.3 Disposable Insulin Pumps to Gain Share over Traditional Insulin Pumps 16
3.4.4 Pain Free Glucose Monitoring Devices Will Drive Future Growth in the Diabetes Care Device Market 18
3.4.5 The Demand for Pain Free Insulin Delivery Devices is Increasing 19
3.4.6 Remote Glucose Monitoring to Bolster Compliance Rate in Diabetics 19
3.5 Diabetes Care Devices Market Drivers 20
3.5.1 New Technologies to Boost Sales in the Future 20
3.5.2 Increasing Prevalence of Diabetes to Boost Sales 21
3.5.3 The Increasing Aging Population of the World to Increase Patient Population 21
3.5.4 Increasing Awareness of Better Diabetes Management 22
3.5.5 Lifestyle Changes Bringing About the Increase in Disease Prevalence 22
3.6 Diabetes Care Devices Market Restraints 22
3.6.1 Lack of Affordability and Awareness in Developing Nations 22
3.6.2 Lack of Reimbursement for New Technologies 22
3.6.3 Low Diagnosis Rate 23
3.6.4 Low Patient Compliance 23
3.6.5 High Cost Is a Restraint for Insulin Pens and Pumps 23
3.6.6 Device Recalls Negatively Affect Physician and Patient Perceptions 23
3.6.7 Low Prescription Rates and Limited Storage Facilities in the Developing World Restraining the Diabetes Care Devices Market 23
3.7 Global Diabetes Care Devices Market, Company Share (%), 2008 24

4 Global Diabetes Care Devices Market: Cross-Segment Market Analysis and Forecasts 25
4.1 Glucose Monitoring Market 25
4.1.1 Global Glucose Monitoring Market, Revenue ($m), 2002 - 2009 25
4.1.2 Global Glucose Monitoring Market, Revenue Forecasts ($m), 2009 - 2016 26
4.1.3 Glucose Monitoring Market Drivers 26
4.1.4 Glucose Monitoring Market Restraints 27
4.1.5 Glucose Monitoring Market by Segment 28
4.2 Insulin Delivery Devices 32
4.2.1 Global Insulin Delivery, Revenue ($m), Global, 2002 - 2009 32
4.2.2 Global Insulin Delivery, Revenue ($m), Global, 2009 - 2016 33
4.2.3 Insulin Delivery Devices Market Drivers 33
4.2.4 Insulin Delivery Devices Market Restraints 34
4.2.5 Insulin Delivery Devices Market by Segment 35

5 Diabetes Care Devices: Competitive Landscape 41
5.1 Insulin Delivery Devices Market 41
5.1.1 Strategic Product Assessment 41
5.1.2 Insulin Delivery Devices, Company Share (%), 2008 42
5.2 Glucose Monitoring Systems 42
5.2.1 Overview 42
5.2.2 Strategic Product Assessment 42
5.2.3 Glucose Monitoring Systems Company Share (%) 43
5.3 Key Company Profiles 44
5.3.1 F. Hoffmann-La Roche Ltd 44
5.3.2 LifeScan (Johnson & Johnson) 44
5.3.3 Bayer Healthcare 44
5.3.4 Abbott Laboratories 44
5.3.5 Becton, Dickinson and Company 44
5.3.6 Medtronic 45
5.3.7 Novo Nordisk 45
5.3.8 Others 45
5.3.9 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market 46
5.3.10 OneTouch UltraMini 47
5.3.11 Contour Meter 48

6 Global Diabetes Care Devices Market: Cross-Country Analysis and Forecasts 49
6.1 Revenue, By Country, 2002 - 2009 49
6.1.1 The US Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 49
6.1.2 Canada Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 50
6.1.3 The UK Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 51
6.1.4 Germany Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 52
6.1.5 France Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 53
6.1.6 Italy Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 54
6.1.7 Spain Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 55
6.1.8 Japan Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 56
6.1.9 China Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 57
6.1.10 India Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 58
6.1.11 Australia Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 59
6.1.12 Brazil Diabetes Care Devices Market, Revenue ($m), 2002 - 2009 60
6.2 Revenue Forecasts, By Country, 2009 - 2016 61
6.2.1 The US Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 61
6.2.2 Canada Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 62
6.2.3 The UK Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 63
6.2.4 Germany Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 64
6.2.5 France Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 65
6.2.6 Italy Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 66
6.2.7 Spain Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 67
6.2.8 Japan Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 68
6.2.9 China Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 69
6.2.10 India Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 70
6.2.11 Australia Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 71
6.2.12 Brazil Diabetes Care Devices Market, Revenue ($m), 2009 - 2016 72

7 Diabetes Care Devices: Pipeline Analysis 73
7.1 Glucose Monitoring Key Pipeline Products 73
7.1.1 Strategic Pipeline Assessment 73
7.1.2 Profiles of Promising Devices under Clinical Development 73
7.1.3 Glucose Monitoring Systems Pipeline Product Summary by Product Type 75
7.1.4 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems 77
7.1.5 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems 79
7.1.6 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems 79
7.2 Future Market Competition in Glucose Monitoring Devices 80
7.3 Global Glucose Monitoring Systems Market: Emerging Companies 80
7.3.1 Introduction 80
7.4 Insulin Delivery Key Pipeline Products 82
7.4.1 Overview 82
7.4.2 Strategic Pipeline Assessment 83
7.4.3 Insulin Delivery Devices - Clinical Pipeline by Mode of Insulin Delivery 83
7.5 Global Insulin Delivery Devices Pipeline Product Summary 84
7.6 Insulin Delivery Devices - Promising Devices under Clinical Development 85
7.6.1 Closed-loop diabetes management system 85
7.6.2 Paradigm Veo System 85
7.6.3 Future Market Competition in Insulin Delivery Devices 86

8 Global Diabetes Care Devices Market: Consolidation Landscape 88
8.1 Deals by Type 2006 - 2009 88
8.2 Key Mergers and Acquisitions, Diabetes Care Devices, 2006 - 2009 89
8.2.1 Bayer HealthCare Completes Acquisition Of iSense 89
8.2.2 Ypsomed Holding Acquires 10% Equity Stake In BIONIME 89
8.2.3 Mediscience Technology Acquires SensiVida Medical Systems 89
8.2.4 Medco Health Solutions Acquires PolyMedica 89
8.2.5 Bayer HealthCare Diabetes Care Acquires Metrika 89

9 Appendix 90
9.1 Methodology 90
9.1.1 Secondary Research 90
9.1.2 Primary Research 91
9.1.3 Models 91
9.1.4 Forecasts 91
9.1.5 Expert Panels 91
9.2 Contact Us 92
9.3 Disclaimer 92

1.1 List of Tables

Table 1: Prevalence of Impaired Glucose Tolerance, 2030, Global 10
Table 2: Diabetes Care Devices, Revenue ($m), Global, 2002 - 2009 12
Table 3: Diabetes Care Devices, Revenue ($m), Global, 2009 - 2016 13
Table 4: Average Cost of Therapy, Traditional Glucose Meter Vs Continuous Glucose Monitor, 2009 15
Table 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 - 2009 17
Table 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 - 2016 18
Table 7: Non Invasive Glucose Monitoring Products 19
Table 8: Oral Insulin Delivery Products under Development, 2009 20
Table 9: Diabetes Mellitus, Estimated Patient Population (‘000's), 2030 21
Table 10: Population Over the age of 65 (‘000's), 2005 - 2010 22
Table 11: Glucose Monitoring, Revenue ($m), Global, 2002 - 2009 25
Table 12: Glucose Monitoring, Revenue ($m), Global, 2009 - 2016 26
Table 13: Blood Glucose Meters, Revenue ($m), Global, 2002 - 2009 28
Table 14: Blood Glucose Meters, Revenue ($m), Global, 2009 - 2016 29
Table 15: Blood Glucose Test Strips, Revenue ($m), Global, 2002 - 2009 30
Table 16: Blood Glucose Test Strips, Revenue ($m), Global, 2009 - 2016 31
Table 17: Comparison of Insulin Delivery Devices 32
Table 18: Insulin Delivery, Revenue ($m), Global, 2002 - 2009 33
Table 19: Insulin Delivery, Revenue ($m), Global, 2009 - 2016 33
Table 20: Insulin Pumps, Revenue ($m), Global, 2002 - 2009 35
Table 21: Insulin Pumps, Revenue ($m), Global, 2009 - 2016 36
Table 22: Insulin Pens, Revenue ($m), Global, 2002 - 2009 37
Table 23: Insulin Pens, Revenue ($m), Global, 2009 - 2016 38
Table 24: Insulin Syringes, Revenue ($m), Global 2002 - 2009 39
Table 25: Insulin Syringes, Revenue ($m), Global 2009 - 2016 40
Table 26: Diabetes Care Devices Market, Revenue ($m), US, 2002 - 2009 49
Table 27: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 - 2009 50
Table 28: Diabetes Care Devices Market, Revenue ($m), UK, 2002 - 2009 51
Table 29: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 - 2009 52
Table 30: Diabetes Care Devices Market, Revenue ($m), France, 2002 - 2009 53
Table 31: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 - 2009 54
Table 32: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 - 2009 55
Table 33: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 - 2009 56
Table 34: Diabetes Care Devices Market, Revenue ($m), China, 2002 - 2009 57
Table 35: Diabetes Care Devices Market, Revenue ($m), India, 2002 - 2009 58
Table 36: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 - 2009 59
Table 37: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 - 2009 60
Table 38: Diabetes Care Devices Market, Revenue ($m), US, 2009 - 2016 61
Table 39: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 - 2016 62
Table 40: Diabetes Care Devices Market, Revenue ($m), UK, 2009 - 2016 63
Table 41: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 - 2016 64
Table 42: Diabetes Care Devices Market, Revenue ($m), France, 2009 - 2016 65
Table 43: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 - 2016 66
Table 44: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 - 2016 67
Table 45: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 - 2016 68
Table 46: Diabetes Care Devices Market, Revenue ($m), China, 2009 - 2016 69
Table 47: Diabetes Care Devices Market, Revenue ($m), India, 2009 - 2016 70
Table 48: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 - 2016 71
Table 49: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 - 2016 72
Table 50: Home Glucose Monitoring Systems Pipeline Product Summary - I 77
Table 51: Home Glucose Monitoring Systems Pipeline Product Summary - II 78
Table 52: Hospital Setting Glucose Monitoring System Pipeline Product Summary 79
Table 53: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary 79
Table 54: Glucose Monitoring Systems Emerging Companies and Products- I 81
Table 55: Glucose Monitoring Systems Emerging Companies and Products - II 82
Table 56: Global Insulin Delivery Devices Pipeline Product Summary 84
Table 57: Closed-loop diabetes management system, Product Status 85
Table 58: Closed-loop diabetes management system, Product Description 85
Table 59: Paradigm Veo System, Product Status 85
Table 60: Paradigm Veo System, Product Description 86
Table 61: Deal Volume By Type, Diabetes Care Devices, 2006-2009 88

1.2 List of Figures

Figure 1: Diabetes Care Devices, Revenue ($m), Global, 2002 - 2009 12
Figure 2: Diabetes Care Devices, Revenue ($m), Global, 2009 - 2016 13
Figure 3: Glucose Monitoring Devices, Distribution Channel Share (%), 2008 15
Figure 4: Insulin Delivery, Distribution Channel Share (%), 2008 16
Figure 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 - 2009 17
Figure 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 - 2016 18
Figure 7: Diabetes Care Devices, Global, Company Share (% in Revenue), 2008 24
Figure 8: Glucose Monitoring, Revenue ($m), Global, 2002 - 2009 25
Figure 9: Glucose Monitoring, Revenue ($m), Global, 2009 - 2016 26
Figure 10: Blood Glucose Meters, Revenue ($m), Global, 2002 - 2009 28
Figure 11: Blood Glucose Meters, Revenue ($m), Global, 2009 - 2016 29
Figure 12: Blood Glucose Test Strips, Revenue ($m), Global, 2002 - 2009 30
Figure 13: Blood Glucose Test Strips, Revenue ($m), Global, 2009 - 2016 31
Figure 14: Insulin Delivery, Revenue ($m), Global, 2002 - 2009 32
Figure 15: Insulin Delivery, Revenue ($m), Global, 2009 - 2016 33
Figure 16: Insulin Pumps, Revenue ($m), Global, 2002 - 2009 35
Figure 17: Insulin Pumps, Revenue ($m), Global, 2009 - 2016 36
Figure 18: Insulin Pens, Revenue ($m), Global, 2002 - 2009 37
Figure 19: Insulin Pens, Revenue ($m), Global, 2009 - 2016 38
Figure 20: Insulin Syringes, Revenue ($m), Global 2002 - 2009 39
Figure 21: Insulin Syringes, Revenue ($m), Global 2009 - 2016 40
Figure 22: Key Insulin Delivery Devices: Strategic Product Assessment 41
Figure 23: Insulin Delivery Devices, Company Share (% in Revenues), 2008 42
Figure 24: Glucose Monitoring Systems: Strategic Product Assessment 43
Figure 25: Glucose Monitoring Systems, Company Share (% in Revenues), 2008 43
Figure 26: Diabetes Care Devices Market, Revenue ($m), US, 2002 - 2009 49
Figure 27: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 - 2009 50
Figure 28: Diabetes Care Devices Market, Revenue ($m), UK, 2002 - 2009 51
Figure 29: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 - 2009 52
Figure 30: Diabetes Care Devices Market, Revenue ($m), France, 2002 - 2009 53
Figure 31: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 - 2009 54
Figure 32: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 - 2009 55
Figure 33: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 - 2009 56
Figure 34: Diabetes Care Devices Market, Revenue ($m), China, 2002 - 2009 57
Figure 35: Diabetes Care Devices Market, Revenue ($m), India, 2002 - 2009 58
Figure 36: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 - 2009 59
Figure 37: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 - 2009 60
Figure 38: Diabetes Care Devices Market, Revenue ($m), US, 2009 - 2016 61
Figure 39: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 - 2016 62
Figure 40: Diabetes Care Devices Market, Revenue ($m), UK, 2009 - 2016 63
Figure 41: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 - 2016 64
Figure 42: Diabetes Care Devices Market, Revenue ($m), France, 2009 - 2016 65
Figure 43: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 - 2016 66
Figure 44: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 - 2016 67
Figure 45: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 - 2016 68
Figure 46: Diabetes Care Devices Market, Revenue ($m), China, 2009 - 2016 69
Figure 47: Diabetes Care Devices Market, Revenue ($m), India, 2009 - 2016 70
Figure 48: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 - 2016 71
Figure 49: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 - 2016 72
Figure 50: Distribution of Pipeline Products by Stage of Development, Glucose Monitoring 73
Figure 51: Glucose Monitoring Systems Pipeline Product by Product Type 75
Figure 52:The Glucose Monitoring Competitive Landscape to Witness a Price War 80
Figure 53: Distribution of Pipeline Products by Stage of Development, Insulin Delivery 83
Figure 54: Insulin Delivery Devices - Clinical Pipeline by Mode of Insulin Delivery 83
Figure 55: The Insulin Delivery Competitive Landscape to Witness a Race to Capture Unmet Need 87
Figure 56: Deal Volume By Type, Global Diabetes Care Devices, 2006-2009 88
Figure 57: Methodology 90